Qiushui He Selected Research

Pertussis Vaccine

12/2022	Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups.
1/2019	Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines.
6/2012	The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.
4/2012	Gene polymorphism in toll-like receptor 4: effect on antibody production and persistence after acellular pertussis vaccination during adolescence.
12/2011	Molecular typing of Bordetella parapertussis isolates circulating in Pakistan.
9/2010	Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults.
9/2009	Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
5/2007	Immunity to pertussis 5 years after booster immunization during adolescence.
5/2005	No evidence of cross-reactivity of human antibodies to a 33-mer peptide of the alpha-gliadin component of gluten with Bordetella pertussis pertactin.
7/2004	Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiushui He Research Topics

Disease

53	Whooping Cough (Pertussis) 12/2022 - 07/2004
25	Bronchiolitis 03/2022 - 06/2012
22	Infections 05/2022 - 01/2002
20	Asthma (Bronchial Asthma) 03/2022 - 09/2012
10	Osteitis 01/2021 - 11/2013
9	Diphtheria 01/2021 - 07/2004
8	Respiratory Sounds (Crackle) 03/2021 - 06/2012
8	Hypersensitivity (Allergy) 02/2021 - 09/2012
8	Tetanus 01/2021 - 07/2004
4	Bacterial Meningitis 04/2022 - 01/2017
4	Allergic Rhinitis 01/2021 - 01/2018
3	With Papillary Renal Neoplasia Papillary Thyroid Carcinoma 01/2018 - 04/2003
3	Respiratory Tract Infections (Respiratory Tract Infection) 05/2017 - 05/2012
3	Otitis Media 05/2017 - 05/2012
3	Reactive Arthritis (Reiter Disease) 01/2012 - 03/2002
2	COVID-19 05/2022 - 01/2022
2	Pneumonia (Pneumonitis) 04/2022 - 05/2012
2	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 04/2021 - 04/2020
2	Tuberculosis (Tuberculoses) 01/2017 - 05/2015
2	Salmonella Infections (Salmonellosis) 01/2012 - 07/2010
1	Blindness (Hysterical Blindness) 04/2022
1	Breakthrough Infections 01/2022
1	Airway Obstruction (Choking) 10/2021
1	Disease Progression 09/2021
1	Viral Bronchiolitis 09/2021
1	Sepsis (Septicemia) 04/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	HIV Infections (HIV Infection) 01/2021
1	Inflammation (Inflammations) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Seizures (Absence Seizure) 01/2017
1	Reinfection 12/2016
1	Atopic Dermatitis (Atopic Eczema) 01/2016
1	Lyme Disease (Disease, Lyme) 01/2015
1	Virus Diseases (Viral Diseases) 06/2012

Drug/Important Bio-Agent (IBA)

38	VaccinesIBA 01/2022 - 04/2003
18	AntibodiesIBA 05/2022 - 04/2003
15	Pertussis ToxinIBA 05/2022 - 06/2008
14	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 09/2012
13	Immunoglobulin G (IgG)IBA 05/2022 - 05/2007
13	CytokinesIBA 01/2022 - 03/2002
11	AntigensIBA 01/2022 - 07/2004
10	Pertussis VaccineIBA 12/2022 - 07/2004
9	Interleukin-17 (Interleukin 17)IBA 03/2022 - 10/2016
8	pertactin FDA Link 01/2021 - 07/2004
8	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2020 - 06/2012
7	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2012
6	Acellular VaccinesIBA 01/2021 - 04/2003
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 06/2012
4	Toll-Like Receptor 10IBA 04/2022 - 01/2017
4	Hemagglutinins (Hemagglutinin)IBA 01/2021 - 07/2004
3	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2019
3	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2022 - 01/2021
3	Toll-Like Receptor 4IBA 10/2021 - 04/2012
3	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 01/2008
3	Interleukin-12 (IL 12)IBA 10/2019 - 01/2016
3	Pentetic Acid (DTPA)FDA LinkGeneric 01/2016 - 09/2010
3	Toll-Like Receptor 2IBA 05/2015 - 12/2013
3	Complement System Proteins (Complement)IBA 01/2015 - 01/2011
3	EnzymesIBA 01/2014 - 05/2005
3	ToxoidsIBA 01/2014 - 09/2010
2	Interleukin-33IBA 01/2021 - 10/2020
2	InterleukinsIBA 10/2020 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 12/2016
2	Oxygen (Dioxygen)IBA 12/2018 - 06/2018
2	MacrolidesIBA 01/2018 - 01/2018
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2012 - 07/2010
2	DNA (Deoxyribonucleic Acid)IBA 08/2006 - 08/2005
1	Messenger RNA (mRNA)IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 10/2021
1	Bronchodilator Agents (Bronchodilators)IBA 10/2021
1	NucleotidesIBA 09/2021
1	Interleukin-12 Subunit p40IBA 04/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2021
1	Adenylate Cyclase ToxinIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	W 12IBA 01/2021
1	Interleukin-13IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	FicolinsIBA 01/2020
1	Interleukin-17 ReceptorsIBA 01/2020
1	EpitopesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	InterferonsIBA 10/2019
1	EnrofloxacinIBA 01/2019
1	Sulfates (Sulfates, Inorganic)IBA 01/2019
1	Vancomycin FDA LinkGeneric 01/2019
1	Erythromycin (Erycette)FDA LinkGeneric 01/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2018
1	Toll-Like Receptor 1IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Immunoglobulin E (IgE)IBA 01/2016
1	Toll-Like Receptor 9IBA 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2016
1	Toll-Like Receptor 3IBA 09/2012

Therapy/Procedure

2	Length of Stay 12/2018 - 06/2018
1	Therapeutics 01/2021
1	Operative Surgical Procedures 12/2016